
Federal Circuit Confirms Generic Drugmakers Can Deduct Hatch-Waxman Litigation Costs
Actavis Laboratories FL, Inc. secures key tax victory as court rules patent defense expenses are immediately deductible business costs
In a landmark decision, the Federal Circuit has ruled that generic pharmaceutical companies may deduct legal expenses incurred in defending Hatch-Waxman patent litigation as ordinary and necessary business expenses. The ruling, which affirms a lower court's decision in favor of Actavis Laboratories FL, Inc., clarifies…







